Custodia Fonseca

Dr. Custodia Fonseca

Universidade do Algarve Faculdade de Ciências e Tecnologia
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2021 in Journal of Chemical Education
Verified
Journal Article
Closed access
Custodia FonsecaCustodia Fonseca
Custodia Fonseca
MZMarielba Zacarias
Marielba Zacarias
MFMauro Figueiredo
Mauro Figueiredo
1

9 July 2001 in Journal of the Chemical Society, Perkin Transactions 2
Verified
Journal Article
Closed access
PDF file
FAF. Brigas Amadeu
F. Brigas Amadeu
WCWilliam Clegg
William Clegg
CDChristopher J. Dillon
Christopher J. Dillon
Custodia FonsecaCustodia Fonseca
Custodia Fonseca
RJRobert A. W. Johnstone
Robert A. W. Johnstone
Pseudosaccharyl and phenyltetrazolyl derivatives 1–6 were prepared with the aim of weakening the originally strong C–N bond in aromatic amines and facilitating its hydrogenolysis. Structural analyses of the amines 1–6 by 1H and 13C NMR spectroscopy and X-ray diffraction methods have revealed major changes in C–N bond lengths on derivatization as a result of changes in conjugation. These changes are discussed in relation to the observed reactivity of compounds 1–6 towards catalytic and non-catalytic C–N bond hydrogenolysis.

1 June 2002 in Journal of Chemical Research
Verified
Journal Article
Closed access
ABAmadeu F. Brigas
Amadeu F. Brigas
Custodia FonsecaCustodia Fonseca
Custodia Fonseca
RJRobert A.W. Johnstone
Robert A.W. Johnstone
Reasons are given for the formation of two different products from the chlorination of saccharin with phosphorus pentachloride: initially 2-chlorosulfonylcyanobenzene is formed which, under appropriate conditions, cyclises to give 3-chloro-1,2-benzisothiazole 1,1-dioxide, an important derivatising agent for alcohols.

14 May 2022 in Biochem
Verified
Journal Article
Open access
PDF file
Custodia FonsecaCustodia Fonseca
Custodia Fonseca
Manuel AurelianoManuel Aureliano
Manuel Aureliano
In this contribution, we provide an overview of gold compound applications against viruses or parasites during recent years. The special properties of gold have been the subject of intense investigation in recent years, which has led to the development of its chemistry with the synthesis of new compounds and the study of its applicability in various areas such as catalysis, materials, nanotechnology and medicine. Herein, thirteen gold articles with applications in several viruses, such as hepatitis C virus (HCV), influenza A virus (H1N1), vesicular stomatitis virus (VSV), coronavirus (SARS-CoV and SARS-CoV-2), Dengue virus, and several parasites such as Plasmodium sp., Leishmania sp., Tripanossoma sp., Brugia sp., Schistosoma sp., Onchocerca sp., Acanthamoeba sp., and Trichomonas sp. are described. Gold compounds with anti-viral activity include gold nanoparticles with the ligands mercaptoundecanosulfonate, 1-octanethiol and aldoses and gold complexes with phosphine and carbene ligands. All of the gold compounds with anti-parasitic activity reported are gold complexes of the carbene type. Auranofin is a gold drug already used against rheumatoid arthritis, and it has also been tested against virus and parasites.

30 August 2020 in Inorganics
Verified
Journal Article
Open access
PDF file
Custodia FonsecaCustodia Fonseca
Custodia Fonseca
GFGil Fraqueza
Gil Fraqueza
Sónia AC CarabineiroSónia AC Carabineiro
Sónia AC Carabineiro
Manuel AurelianoManuel Aureliano
Manuel Aureliano
The therapeutic applications of gold are well-known for many centuries. The most used gold compounds contain Au(I). Herein, we report, for the first time, the ability of four Au(I) and Au(III) complexes, namely dichloro (2-pyridinecarboxylate) Au(III) (abbreviated as 1), chlorotrimethylphosphine Au(I) (2), 1,3-bis(2,6-diisopropylphenyl) imidazole-2-ylidene Au(I) chloride (3), and chlorotriphenylphosphine Au(I) (4), to affect the sarcoplasmic reticulum (SR) Ca2+-ATPase activity. The tested gold compounds strongly inhibit the Ca2+-ATPase activity with different effects, being Au(I) compounds 2 and 4 the strongest, with half maximal inhibitory concentration (IC50) values of 0.8 and 0.9 µM, respectively. For Au(III) compound 1 and Au(I) compound 3, higher IC50 values are found (4.5 µM and 16.3 µM, respectively). The type of enzymatic inhibition is also different, with gold compounds 1 and 2 showing a non-competitive inhibition regarding the native substrate MgATP, whereas for Au compounds 3 and 4, a mixed type of inhibition is observed. Our data reveal, for the first time, Au(I) compounds with powerful inhibitory capacity towards SR Ca2+ATPase function. These results also show, unprecedently, that Au (III) and Au(I) compounds can act as P-type ATPase inhibitors, unveiling a potential application of these complexes.

1 March 2006 in Journal of Molecular Catalysis A: Chemical
Verified
Journal Article
Closed access
ABAmadeu F. Brigas
Amadeu F. Brigas
Custodia FonsecaCustodia Fonseca
Custodia Fonseca
RJRobert A.W. Johnstone
Robert A.W. Johnstone